GAPL 1 – Green Lane
Project Objectives
Pharma.Aero launched a series of projects on environmental sustainability in the life sciences and medtech logistics industry. The first project of the Green Air Pharma Logistics (GAPL) series focuses on defining a green lane to support pharma manufacturers, shippers, and freight forwarders in their sustainability consideration during the lane assessment process and towards their Scope 3 decarbonisation targets. Also, the project comes as an important support for air cargo stakeholders in pursuing green air logistics initiatives as part of their Scope 1 decarbonization efforts. Â
Pharma.Aero engages its global network of value chain stakeholders (shippers, airports, cargo handlers, airlines, solution providers, regulators etc.) to actively participate in all phases of the project. Â
The conclusion of this project would open up new areas for further pursuits. Â
Project Purpose
The first Green Air Pharma Logistics (GAPL) project focuses on the Green Lane, with the purpose of developing a set of standards and measurements to qualify and quantify a green air lane in the life science and medtech supply chain industry.Â
Project Status And Key-takeaways
The project consists of 3 Work Packages: Work Package 1 – Baselining and Setting up the Industry Problem Statement (April – September 2023):
- Desk researchÂ
- Series of interviews with pharma manufacturers, airlines, and freight forwarders to gain deeper insights into their business practices and sustainability considerations (21 interviews: 7 pharmaceutical manufacturers, 6 freight forwarders and 8 airlines)
- Interim Report providing context and delving into the key findings and takeaways of the interviews
- Workshop: based on the interim report, engaging stakeholders participating in the Pharma Logistics Masterclass to help define the qualitative and quantitative measurements, as well as standards, of a Green Air Pharma Lane (Day 5 of the PLMC in Singapore)
Work Package 2 – Defining Green Air Pharma Corridor (October – November 2023):
- Definition of a ‘Green Lane’Â
- Identify the standards, measurement and evaluation criteria to quantify and qualify a green lane Â
- Identify potential partners (third-party organisations and institutions) in areas including but not restricted to emissions measurement
Work Package 3 – Publications (December 2023 – March 2024): publish Technical Report and White Paper, identify spin-off projects.
PROJECT
SUPPORT AND
COLLABORATION.
- Pharma.Aero Board liaison: Brussels Airport
- Project lead: Changi Airport Group
- Project interviewees: Bayer, GSK, MSD, Novartis, Pfizer, Roche, Zoetis, Expeditors, Geodis, JAS, Kuehne+Nagel, PSA BDP, Rhenus Logistics, Air Canada, ANA Cargo, Cathay Pacific, Etihad, Lufthansa Cargo, Qatar Airways, Singapore Airlines, Turkish Cargo.
- Project manager: Céline Crahay, 3CeL (external consultant)